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Plasmid profile of Extended Spectrum 4-lactamases (ESBL)-producing 
Enterbacteriaceae in Jordan 
Suhaila Al-sheboul 
 
Background: Extended spectrum %-lactamases (ESBL)-producing organisms pose unique challenges to clinical 
microbiologists, clinicians, infection control professionals and antibacterial-discovery scientists. Members of 
family Enterobacteriaceae can acquire resistance to extended spectrum beta lactams by a number of mechanisms; 
most important being the plasmid encoded extended spectrum beta lactamase (ESBL) and AmpC beta lactamase. 
The purpose of this study was to determine the presence of plasmids and their correlation with drug resistance of 
ESBL-producing K. pneumoniae and E. coli and to investigate the prevalence of these plasmid profiles in North 
of Jordan. Methods: ESBL production was studied in K. pneumoniae and E. coli and susceptibility testing of 
ESBL positive isolates was done for various beta lactams, cephalosporins, monobactams and other commonly 
used drugs against them. Plasmid DNA isolation of all the ESBL positive strains was done by alkalilysis method. 
The presence of plasmid was correlated with susceptibility to beta lactam drugs. Results: E. coli, K. pneumoniae, 
harbored multiple plasmids. The number of plasmids ranged from 1 to 9. Five plasmid profiles (A, B, C, D and 
E) were found in E. coli isolates and three plasmid profiles (A, B and C) were found in K. pneumoniae isolates. 
Among the different plasmid profiles profile C and D in E. coli and profile C in K. pneumoniae were the most 
resistant to antibiotics. One plasmid (M.W greater than 23 kbp) was present in 90% of all isolates. Also, the 
results showed that about 96% of the E. coli and K. pneumoniae isolates are multidrug resistant. Conclusion: 
There is a strong correlation between the number of plasmids harbored by an isolate and resistance to various 
drugs tested. 
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Introduction: The emergence and rapid dissemination of carbapenemase (CARB)-producing 
Enterobacteriaceae has become an important therapeutic and infection control problem in Europe. In Portugal, 
according to the European Antimicrobial Resistance Surveillance Network (EARS-Net) surveillance study, there 
was an increase in carbapenem nonsusceptibility of K. pneumoniae isolates from 0.72% in 2008 to 1.58% in 
2010. However, little is known on CARB-producing Enterobacteriaceae. KPC enzymes have not been described 
in portuguese clinical Enterobacteriaceae isolates, but a KPC-2-producing E. coli isolate was recently found in 
the aquatic environment.  
Methods: In this study, we report 6 KPC-3-producing Enterobacteriaceae isolates (5 K. pneumonia and 1 
Enterobacter cloacae), collected between March 2010 and December 2011 and sent to the NIH-Lisbon for 
carbapenem susceptibility confirmation. Antimicrobial susceptibility of clinical isolates was performed by disk 
diffusion method. PCR and sequencing were applied to detect and identify CARB-encoding genes as well as 
blaESBL and blaPMA: (plasmid-mediated AmpC :-lactamases); the respective genetic environment was revealed by 
sequencing using PCR mapping, after standard cloning experiments. Direct transfer of the carbapenem resistance 
phenotype was attempted by mating-out assays. Antibiotics susceptibility (MIC) of transconjugants and 
respective isolates were tested by microdilution and the results were interpreted according to EUCAST 
breakpoints. The plasmids obtained for all isolates were characterized by PCR-based replicon typing (PBRT). 
Clonal relatedness of the 5 K. pneumoniae isolates was investigated by multilocus sequence typing (MLST), 
using the protocol developed by the Institute Pasteur (www.pasteur.fr/mlst/Kpneumoniae.html). 
Results: The majority of isolates were collected from the urine (42.8%) of elderly (?65 years old) male patients 
(85.7%), admitted at four geographic distant Portuguese hospitals. The KPC-3 producers displayed a MDR 
phenotype with consistent susceptibility only to colistin and tigecycline. All isolates demonstrated a positive 
combined disk test with meropenem and meropenem-boronic acid, indicative of serine CARB production. 
Overall, the blaKPC-3 gene was confirmed in all isolates, alone or in combination with other bla genes, namely 
blaSHV-26, an inhibitor-resistant SHV; blaCTX-M-15, the most frequent ESBL-type found worldwide; and the blaSHV-
164 (HE981194), here firstly described. No co-expression of KPC-3 with other CARB or PMA: was detected. 
Recombinant plasmids with a 4,110 bp insert conferring resistance to carbapenems were obtained after cloning 
experiments. Genetic mapping around the blaKPC-3 gene identified the Tn3-like Tn4401 transposon. In this study, 
we detected, in all isolates, the 68-bp deletion isoform, which ends upstream of the -35 region of the promoter. In 
our study, the majority of the blaKPC-3-harboring plasmids appear to be nonconjugative, since only one conjugant 
[EcK12 C600 (INSRA14159-KPC-3)] and one transformant [EcDH5H (INSRA12267-KPC-3)] were obtained. In 
general, both transformants had antibiotic resistance profiles similar to those of their parental clinical isolates. All 
but two KPC-3-producing isolates were positively typed by the PBRT method: IncFrepB + IncFIIs (n=3), IncFrepB 
+ IncP (n=1) and IncFrepB (n=1). Both conjugant and transformant had only the IncFrepB, suggesting that this Inc 
group is associated with KPC-3-harbouring plasmids. The KPC-3-producing K. pneumoniae were from distinct 
sequence types, namely ST14, which have been associated with NDM-producing K. pneumoniae, ST34, ST59, 
ST416 and the novel ST960.
Conclusion: This study provides new data regarding the molecular epidemiology of CARB-producing 
Enterobacteriaceae in Portugal, which includes KPC-3-harbouring IncFrepB plasmids that are shared by 
polyclonal K. pneumoniae and E. cloacae clinical strains. Overall, our results emphasize the need of a concerted 
action to manage carbapenem use.
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